Stonebridge Financial Group LLC purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 514 shares of the company’s stock, valued at approximately $83,000.
Several other hedge funds have also made changes to their positions in CLX. State Street Corp increased its stake in Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after acquiring an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC grew its holdings in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the period. Geode Capital Management LLC raised its holdings in Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after buying an additional 33,970 shares during the period. Stifel Financial Corp lifted its position in Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after buying an additional 37,967 shares during the last quarter. Finally, Van ECK Associates Corp boosted its stake in Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after buying an additional 31,510 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Analyst Upgrades and Downgrades
CLX has been the subject of a number of recent analyst reports. Wells Fargo & Company lifted their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. DA Davidson cut their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, Evercore ISI raised their target price on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $158.21.
Clorox Trading Up 0.2 %
Shares of NYSE:CLX opened at $148.66 on Thursday. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company’s 50 day moving average is $160.30 and its two-hundred day moving average is $159.26. The company has a market cap of $18.40 billion, a PE ratio of 40.62, a P/E/G ratio of 2.52 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52.
Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the firm earned $2.16 EPS. Equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.28%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 133.33%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- When to Sell a Stock for Profit or Loss
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Health Care Stocks Explained: Why You Might Want to Invest
- Inflation Persists, But So Do Stock Opportunities: Rally On
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.